Phase III to Evaluate Patient´s Preference of Subcutaneous Trastuzumab vs Intravenous in HER2+ Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Trastuzumab Injectable Solution|DRUG: Trastuzumab Injectable Product|DRUG: Trastuzumab Injection
Sponsor: Spanish Breast Cancer Research Group